Senior Associate Scientist - Bioanalysis
Regeneron Pharmaceuticals
Summary
Regeneron Pharmaceuticals is a leading American biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company specializes in inventing, developing, and commercializing life-transforming medicines for people with serious diseases. Regeneron is renowned for its innovative antibody technologies and has developed several groundbreaking therapies, including EYLEA® for retinal diseases, DUPIXENT® for inflammatory conditions, and the COVID-19 antibody cocktail REGEN-COV®. The company operates with a strong focus on research and development across multiple therapeutic areas including ophthalmology, oncology, cardiovascular diseases, and rare genetic disorders. Regeneron's proprietary VelocImmune® technology platform enables the rapid generation of fully human monoclonal antibodies. With over 15,000 employees globally and annual revenues exceeding $14 billion, Regeneron has established itself as a major force in the biotechnology industry, consistently ranking among the top-performing pharmaceutical companies and maintaining a robust pipeline of investigational therapies.
Job description
Discover your role
- Trains on and executes bioanalytical methods to perform bioanalysis for clinical and nonclinical studies under minimal supervision.
- Analyzes multiple plates within the same day and can effectively switch gears when performing different assays or assay types.
- Regularly generates high-quality data and documentation, limiting the number of analyst-related deviations.
- Exhibits independence when performing bioanalysis activities. Demonstrates accountability for the data generated, by independently interpreting data to assess assay performance and identify assay-related anomalies. Determines appropriate sample dilutions.
- Executes necessary operations in LIMS (requesting samples, plate building, tracking sample movement, tracking pending analysis and performing data entry). May utilize LIMS to assess data and track assay performance.
- Utilizes the ELN to document experimental procedures. Works closely with Quality Control (QC) to address documentation findings and minimize deviations.
- May review/edit bioanalytical method procedures (BMPs) for use with assigned programs.
- Prepares and qualifies reagents. Re-orders laboratory supplies and reagents, as needed. May communicate with internal groups and outside vendors to obtain assay-related reagents.
- Performs development experiments to troubleshoot assay-related issues under minimal supervision. Summarizes data under minimal supervision. Presents data in a logical manner to Management.
- Actively participates in and presents work at sub-team/group meetings. May present data at department meetings.
- May contribute to posters and/or manuscripts.
- Provides cross-functional support to other teams or groups. May perform method validation/qualification activities.
- Ensures compliance, as appropriate, for laboratory work and documentation in accordance with working practices, company SOPs, bioanalytical method procedures (BMPs), and regulations (e.g., GLP and GCP).
- Responsible for own safety in the laboratory, as well as for the safety of co-workers and visitors.
- May be responsible for bioanalysis activity coordination for a clinical and/or nonclinical program under direct supervision of Management.
- May serve as team representative for project communication during planning/deliverable meetings. Contributes to discussions regarding resourcing, deliverables, assay-related issues, etc.
- Prepares study/program specific documentation.
- May train or provide general support/assistance to other laboratory staff.
- May support method transfer activities, including reagent coordination, coordination of software-related administrative tasks, creation of ELN/SoftMax templates, and other necessary software activities.
This role requires
- Engage in strong two-way communication with Management and team members. Collaborates successfully with other team members.
- Adapt to changing priorities and deliverables.
- Actively participates in their own professional and personal development. Communicates effectively with their manager with respect to performance management and is open to receiving/giving feedback.
- Demonstrate scientific curiosity around the concepts and designs of the work performed.
- Contribute to process improvement initiatives within the group.
- A Bachelor's or Master's degree.
- Typically, a minimum of 3+ years of relevant post-degree experience for Bachelor's or Master's degree.
Requirements
- Bachelor's or Master's degree
- Minimum of 3+ years of relevant post-degree experience
- Experience executing bioanalytical methods for clinical and nonclinical studies
- Experience with LIMS and ELN
- Knowledge of GLP and GCP regulations
- Ability to interpret assay data and troubleshoot technical issues
- Strong communication and collaboration skills
Benefits
- Annual bonuses
- Incentive plans
- Equity awards
- Pension or retirement benefits
- 401(k) company match
- Health and wellness programs
- Fitness centers
- Medical, Dental & Vision
- Life and disability insurance
- Paid time off
- Family support benefits
Company overview
Regeneron Pharmaceuticals is a leading American biotechnology company founded in 1988 and headquartered in Tarrytown, New York. The company specializes in inventing, developing, and commercializing life-transforming medicines for people with serious diseases. Regeneron is renowned for its innovative antibody technologies and has developed several groundbreaking therapies, including EYLEA® for retinal diseases, DUPIXENT® for inflammatory conditions, and the COVID-19 antibody cocktail REGEN-COV®. The company operates with a strong focus on research and development across multiple therapeutic areas including ophthalmology, oncology, cardiovascular diseases, and rare genetic disorders. Regeneron's proprietary VelocImmune® technology platform enables the rapid generation of fully human monoclonal antibodies. With over 15,000 employees globally and annual revenues exceeding $14 billion, Regeneron has established itself as a major force in the biotechnology industry, consistently ranking among the top-performing pharmaceutical companies and maintaining a robust pipeline of investigational therapies.